ReviewMaterials today. Bio2025
Multifunctional hydrogels for synergistic therapy of cutaneous melanoma-associated tumor recurrence and wound regeneration.
Review in Materials today. Bio, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Novel insights into extracellular vesicles: An update on biomolecules, immunomodulation and clinical strategies in skin melanoma.Clinical and translational medicine · 2026Review
- Exploring of therapeutic potential of indirubin-loaded nanofibrous scaffolds for localized melanoma treatment.Journal of biological engineering · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous melanoma is a highly aggressive malignant tumor originated from melanocytes, and its postoperative recurrence and metastatic risk seriously threaten patient survival. Traditional treatments like surgical resection and chemoradiotherapy can merely control the disease in the short term, which faces severe limitations such as immunosuppression of tumor microenvironments (TME), drug resistance and systemic toxicity. Local recurrence, wound infection, and slow healing are common challenges in melanoma post-operation. In recent years, synergistic therapeutic strategies based on multifunctional hydrogels have been at the forefront of research due to their exceptional biomaterial properties, such as high biocompatibility, programmable drug release and tissue regeneration support. Different types of complexes are utilized to synthesize multifunctional hydrogels in different oncology therapeutic application scenarios, and various novel preparation processes and powerful functional components are introduced. Hydrogels have the ability to achieve responsive-triggered precision drug delivery, forming a synergistic system in immunotherapy, radiotherapy and phototherapy, reverse the inhibitory TME, and exert powerful anti-tumor effects through multiple signaling pathways. In addition, its improved hydrophilicity and biomimetic microcellular structure could accelerate postoperative wound regeneration, and the combination of antimicrobial components can effectively prevent postoperative wound infections resulting from disturbed local immune microenvironment. In this paper, we systematically reviewed and summarized the cutting-edge advances of hydrogels used for treating cutaneous melanoma, focusing on their functionalized design, anti-tumor molecular mechanisms, immune microenvironment regulation, antibacterial efficacy and synergistic strategies of wound regeneration, with a view to providing theoretical basis and technical references for future clinical translation of tissue engineering materials for tumor-associated wounds.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.